The B. fragilis PSA can suppress inflammatory bowel disease and experimental autoimmune encephalomyelitis (EAE) through activating helper T cells that express the surface protein CD4 (CD4+ T cells) through a mechanism dependent on the major histocompatibility complex class II (MHCII) [63]. The gene discussed is CD4; the disease is experimental autoimmune encephalomyelitis.